Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (81-90 of 340) with videos related to

Pageof 34
Sort By:
Expert Opinion on Emerging Drugs|June 20, 2026
Obefazimod (ABX464) for Moderate-to-Severe Crohn's disease: clinical development of a novel oral therapeutic approachSailish Honap, Axel Dignass, Vipul Jairath, et al.
Journal of Crohn'S & Colitis|May 26, 2012
Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literatureCândida Abreu, Fernando Magro, Filipe Vilas-Boas, et al.
Inflammatory Bowel Diseases|October 16, 2020
Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel DiseaseMariana Ferreira-Duarte, Maria Manuela Estevinho, Margarida Duarte-Araújo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 8, 2016
The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patientsCândida Abreu, Francisco Almeida, Rita Ferraz, et al.
Journal of Crohn'S & Colitis|June 13, 2017
Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα TherapyCândida Abreu, Joana Afonso, Cláudia Camila Dias, et al.
World Journal of Gastroenterology|November 1, 2017
Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic stricturesSusana Lopes, Patrícia Andrade, Eduardo Rodrigues-Pinto, et al.
Inflammatory Bowel Diseases|July 18, 2013
Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysisJoão Costa, Fernando Magro, Daniel Caldeira, et al.
Journal of Crohn'S & Colitis|April 28, 2015
Clinical trials in ulcerative colitis: a historical perspectivePieter Hindryckx, Filip Baert, Ailsa Hart, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2026
Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality?Virginia Solitano, Vipul Jairath, Fernando Magro, et al.
Experimental Physiology|November 10, 2015
Amine neurotransmitters, inflammation and epithelial sodium transportPatrício Soares-da-Silva, José Miguel Cabral, Diogo Magalhães, et al.
Pageof 34

Showing results (81-90 of 340) with videos related to

Sort By:
Pageof 34
Expert Opinion on Emerging Drugs|June 20, 2026
Obefazimod (ABX464) for Moderate-to-Severe Crohn's disease: clinical development of a novel oral therapeutic approachSailish Honap, Axel Dignass, Vipul Jairath, et al.
Journal of Crohn'S & Colitis|May 26, 2012
Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literatureCândida Abreu, Fernando Magro, Filipe Vilas-Boas, et al.
Inflammatory Bowel Diseases|October 16, 2020
Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel DiseaseMariana Ferreira-Duarte, Maria Manuela Estevinho, Margarida Duarte-Araújo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 8, 2016
The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patientsCândida Abreu, Francisco Almeida, Rita Ferraz, et al.
Journal of Crohn'S & Colitis|June 13, 2017
Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα TherapyCândida Abreu, Joana Afonso, Cláudia Camila Dias, et al.
World Journal of Gastroenterology|November 1, 2017
Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic stricturesSusana Lopes, Patrícia Andrade, Eduardo Rodrigues-Pinto, et al.
Inflammatory Bowel Diseases|July 18, 2013
Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysisJoão Costa, Fernando Magro, Daniel Caldeira, et al.
Journal of Crohn'S & Colitis|April 28, 2015
Clinical trials in ulcerative colitis: a historical perspectivePieter Hindryckx, Filip Baert, Ailsa Hart, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2026
Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality?Virginia Solitano, Vipul Jairath, Fernando Magro, et al.
Experimental Physiology|November 10, 2015
Amine neurotransmitters, inflammation and epithelial sodium transportPatrício Soares-da-Silva, José Miguel Cabral, Diogo Magalhães, et al.
Pageof 34